Doug Monroe of Kaiser Permanente's 2015 Presentation

Kaiser Permanente: the impact of biosimilars on private reimbursement

We were excited to have Doug Monroe, Project Manager of Biotechnology, Emerging Technology, and Specialty Pharmacy at Kaiser Permanente, share his expertise on the impact of biosimilars on private reimbursement strategies at the World Biosimilar Congress USA. Download his presentation now > You can now download Doug’s presentation to find out more about: The Kaiser Permanente integrated health care delivery system …

Download Ebook: Top 20 Big Data projects in Pharma & Biotech – Part 1

The promise of big data Every patient experience generates a massive amount of data which, when pooled together, can give a detailed account of their health, the effectiveness & safety of the drugs they are taking and when aggregated from other patient's data a vast library of information about entire disease states and clinical populations. Understandably pharma is now armouring …